Brief: Ebr Systems Receives FDA Approval For Wise CRT System
April 14 (Reuters) - EBR Systems Inc EBR.AX: FDA APPROVAL FOR WISE CRT SYSTEM Further company coverage: EBR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026